Tumor rejection and immunotherapy studies with simian virus 40-induced tumors
Blakeslee, J.R.; von Muenchhausen, W.; Cox, H.R.
Journal of Medicine 4(4): 233-247
1973
ISSN/ISBN: 0025-7850 PMID: 4358481 Document Number: 65362
Document emailed within 1 workday
Related Documents
Bright, R.K.; Shearer, M.H.; Kennedy, R.C. 1994: Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity Journal of Immunology 153(5): 2064-2071Drapkin, M.S.; Appella, E.; Law, L.W. 1974: Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40 Journal of the National Cancer Institute 52(1): 259-264
Diamandopoulos, G.T.; Miller, M.H.; McLane, M.F.; Evans, P.G. 1976: Loss or persistence of the differentiated state of simian virus 40-induced hamster tumor cells before and after serial passage in culture Cancer Research 36(9 Pt.1): 3171-3177
Zerrahn, J.; Utermöhlen, O.; Warnecke, G.; Deppert, W.; Lehmann-Grube, F. 1996: Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes Journal of Immunology 156(10): 3919-3924
Coggin, J.H.; Gillis, L.D.; Payne, W.J. 1984: Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride Journal of the National Cancer Institute 72(4): 853-862
Patch, C.T.; Hauser, J.; Lewis, A.M.; Levine, A.S. 1983: Suppression of the simian virus 40 tumorigenic phenotype in hybrid cells formed from simian virus 40- and adenovirus 2-transformed hamster embryo cells Cancer Research 43(6): 2571-2575
Rachlin, J.; Wollmann, R.; Dohrmann, G. 1988: Inoculation of simian virus 40 into pregnant hamsters can induce tumors in offspring Laboratory Investigation; a Journal of Technical Methods and Pathology 58(1): 26-30
Rizzo, P.; Di Resta, I.; Powers, A.; Matker, C.M.; Zhang, A.; Mutti, L.; Kast, W.M.; Pass, H.; Carbone, M. 1998: The detection of simian virus 40 in human tumors by polymerase chain reaction Monaldi Archives for Chest Disease 53(2): 202-210
Weiland, E.; Mussgay, M. 1975: Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 150(5): 414-423
Poulin, L.; Spira, B.; Wainberg, M.A. 1987: Studies on pp60src and associated kinase activity in regressing tumors induced by Rous sarcoma virus In Vivo 1(2): 125-130
Horvath, C.J.; Desrosiers, R.C.; Sehgal, P.K.; King, N.W.; Ringler, D.J. 1991: Effect of simian immunodeficiency virus infection on tumor necrosis factor-alpha production by alveolar macrophages Laboratory Investigation; a Journal of Technical Methods and Pathology 65(3): 280-286
Houchens, D.P.; Goldberg, A.I.; Gaston, M.R.; Kende, M.; Goldin, A. 1973: Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice Cancer Research 33(4): 685-690
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
Ohtaki, S. 1978: Suppressive effects on simian virus 40-induced oncogenesis of several immunosuppressive agents and hormonal modifications applied during the latent period Cancer Research 38(12): 4698-4710
Lamm, D.L.; Harris, S.C.; Gittes, R.F. 1977: Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors Investigative Urology 14(5): 369-372
Li, Q.-L.; Wang, Y.-P.; Gao, S.-F.; Ma, J.; Feng, C.-X.; Wang, Y.-L. 2009: Animal experiments of immunotherapy with ovarian tumor vaccine during lymphopenia induced by chemotherapy Zhonghua Fu Chan Ke Za Zhi 44(11): 856-860
De Leo, A.B.; Becker, M.; Lu, L.; Law, L.W. 1993: Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma Cancer Research 53(7): 1602-1607
Negroni, G.; Hunter, E. 1973: Rejection of polyoma virus-induced neoplasms in mice inoculated with complement and antiserum Journal of the National Cancer Institute 51(1): 265-268
Rhim, J.S.; Cho, H.Y.; Kim, J.M.; Green, I. 1976: Characterization of virus-free guinea pig tumors induced by Kirsten sarcoma virus Journal of the National Cancer Institute 56(6): 1233-1236
Martin, W.J.; Esber, E.; Cotton, W.G.; Rice, J.M. 1975: Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor Journal of Immunology 115(1): 289-295